Efficacy of Proprioceptive Neuromuscular Facilitation in Older Women With Gonarthrosis

Efficacy of Proprioceptive Neuromuscular Facilitation About Functional Performance, Pain and Quality of Life in Older Women With Gonarthrosis: Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02919020

Acronym

PNF

Enrollment

Registered

2016-09-29

Start date

2017-01-31

Completion date

2019-02-28

Last updated

2021-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis Knee

Keywords

Proprioceptive Neuromuscular Facilitation (PNF ), resistance exercise

Brief summary

To evaluate the effectiveness of the method Proprioceptive Neuromuscular Facilitation (PNF) as physical therapy approach to the reduction of pain and improvement in functional performance and quality of life in women with knee osteoarthritis.

Detailed description

Patients will be divided into two groups: group perform proprioceptive neuromuscular facilitation and other group submit performing resistance exercises.

Interventions

OTHERProprioceptive neuromuscular facilitation (PNF)

Proprioceptive neuromuscular facilitation, using the technique of rhythmic initiation and Combination of Isotonic on lower members

OTHERResistance exercise

resistance exercise to strengthen lower limbs

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

50 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Women; * Age between 50 and 80 years; * Clinical diagnosis of Osteoarthritis of knees ; * Patients with presence of at least 90 ° range of motion of knee flexion ; * Do not practitioners of physical exercise and physical therapy during the period of participation in the survey

Exclusion criteria

* Diagnosis of other rheumatological and neurological diseases ; * orthopedic surgery History in the lower limbs ; * Individuals with muscle strength of the lower limbs \<3 ; * Cognitive impairment or neurological disease that compromises the understanding and implementation of the Protocol (Mini Mental State Examination \<18 for the illiterate and \<24 for others); * Body mass index ≥ 30.0 (obesity , according to the World Health Organization ) . * Individuals classified as physical activity level very active by the IPAQ (International Physical Activity Questionnaire ) .

Design outcomes

Primary

Measure	Time frame	Description
Change in pain	change from baseline in pain 6th - 12th week	Pain control diary
Quality of life	change from baseline in quality of life 6th-12th week	Western Ontario and McMaster Universities Questionaire
Functional performance	Change based on functional performance 6th - 12th week	30 s -chair stand test
Functional Performance	Change based on functional performance 6th - 12th week	Walk Test of 40 meters at a rapid pace

Secondary

Measure	Time frame	Description
pain sensitivity threshold	change from baseline in pain threshold 6th-12th week pressure	Algometry
Range of motion	change from baseline in the range of knee flexion 6th-12th week	Universal Goniometer

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026